Peer-reviewed veterinary case report
Dalmatian dog treated for portal vein blood clot with implanted port
By Yoshida, Tomohiko et al.·Published in Open veterinary journal·2022·Department of Veterinary Surgery, Japan·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Treatment of portal vein thrombosis using vascular access port implantation in a Dalmatian dog: A case report.
- Species:
- dog
Plain-English summary
A 10-year-old Dalmatian was brought in for fainting spells and high levels of waste products in the blood. After tests, the dog was diagnosed with acute portal vein thrombosis, a serious condition that can lead to severe complications. To treat this, a special port was implanted in the abdomen to deliver medication directly, and low-molecular-weight heparin was used to manage the blood clot. The dog responded well to the treatment, with symptoms resolving and no signs of relapse six months later.
People also search for: Dalmatian fainting spells · dog portal vein thrombosis treatment · low-molecular-weight heparin for dogs
Abstract
BACKGROUND: Portal vein thrombosis is a disease with potentially deleterious outcomes including portal vein hypertension and intestinal infarction. The factors contributing is various; however, dogs with with acute portal vein thrombosis or multiple thromboses are less likely to survive. Therefore, acute development of portal hypertension has a requires an immediate treatment. CASE DESCRIPTION: A 10-year-old Dalmatian was referred for syncope and azotemia, hyperammonemia. After each examinations including computed tomography scan, we diagnosed with acute portal vein thrombosis with unknown cause. A portal vein port was inserted to prevent and control the portal vein thrombus. The port was placed in abdomen subcutaneously after the position of the catheter were stabilized. Low-molecular-weight heparin was injected from the port to manage thrombosis after the operation. This case responded well to this treatment. Syncope and azotemia, hyperammonemia resolved and no relapse of thrombosis was found 6 months after the operation. CONCLUSION: Implantable vascular access port is a drug delivery system with the advantage of dealing with treatment-resistant acute portal vein thrombosis.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/35821776/